Total Funding
55
1
Total FundingSeries C raised
Growth Score
-17 pts
Heat Score
-34 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
3732261
TaiGen is a pharmaceutical company discovering, developing and commercializing drugs to treat cancers, infectious diseases and diabetics.
Ming Hsu: Founder, President & CEOPast Role: The Rockefeller University, Assistant Professor
About the Company
TaiGen Biotechnology Co. is a pharmaceutical company based in Taiwan. The company focuses on the discovery, development and commercialization of therapeutics to treat cancers, infectious diseases and diabetic complications (limb ischemia and retinopathy). TaiGen currently has operations in Taiwan, China, and the U.S.
